Keyword Connections

•  Adetola Kassim
•  Bruce Damon

•  David Robertson
•  Jacklyn Hellwege

•  Scott Jafarian Kerman
•  Swati Rane

Resources

• Cardiovascular Pathophysiology & Complications Core - Industry-Initiated Cost for Services
• Cardiovascular Pathophysiology & Complications Core - Investigator-Initiated Research
• Cardiovascular Pathophysiology & Complications Core List of Services
• Cardiovascular Pathophysiology Core (with Cardiovascular Medicine)
• Insulin tolerance test (ITT)
• Saphenous vein blood collection

Communities

• No matching connections

Publications

• Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.
  Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ
  (1998) N Engl J Med 339: 1285-92
• Factor XI antisense oligonucleotide for prevention of venous thrombosis.
  Büller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, Segers A, Verhamme P, Weitz JI, FXI-ASO TKA Investigators
  (2015) N Engl J Med 372: 232-40
• Clinical implications of prostaglandin and thromboxane A2 formation (1).
  Oates JA, FitzGerald GA, Branch RA, Jackson EK, Knapp HR, Roberts LJ
  (1988) N Engl J Med 319: 689-98
• A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
  SPRINT Research Group, Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT
  (2015) N Engl J Med 373: 2103-16
• The neuropathic postural tachycardia syndrome.
  Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, Biaggioni I, Ertl A, Black B, Robertson D
  (2000) N Engl J Med 343: 1008-14
• The diagnosis and treatment of baroreflex failure.
  Robertson D, Hollister AS, Biaggioni I, Netterville JL, Mosqueda-Garcia R, Robertson RM
  (1993) N Engl J Med 329: 1449-55
• Clinical problem-solving. High time for action.
  Kallianpur AR, Poehling KA, Dittus RS
  (2001) N Engl J Med 344: 48-51
• Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency.
  Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D
  (2000) N Engl J Med 342: 541-9
• Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.
  Arnaout MA, Hakim RM, Todd RF, Dana N, Colten HR
  (1985) N Engl J Med 312: 457-62
• Intensive blood-pressure control in hypertensive chronic kidney disease.
  Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X, AASK Collaborative Research Group
  (2010) N Engl J Med 363: 918-29
• Transfusions for silent cerebral infarcts in sickle cell anemia.
  DeBaun MR, Casella JF
  (2014) N Engl J Med 371: 1841-2
• Serotonin rising.
  Anderson GM, Cook EH, Blakely RD
  (2009) N Engl J Med 360: 2580; author reply 2581-2
• Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation.
  FitzGerald GA, Smith B, Pedersen AK, Brash AR
  (1984) N Engl J Med 310: 1065-8
• Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?
  White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, Marcus ML
  (1984) N Engl J Med 310: 819-24
• The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.
  Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ
  (2001) N Engl J Med 345: 1030-5
• The effect of aprotinin on outcome after coronary-artery bypass grafting.
  Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF
  (2008) N Engl J Med 358: 784-93
• Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
  DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS, Hirtz D, Casella JF
  (2014) N Engl J Med 371: 699-710
• Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension.
  Onrot J, Goldberg MR, Biaggioni I, Hollister AS, Kingaid D, Robertson D
  (1985) N Engl J Med 313: 549-54
• Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies.
  Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, Burnett MS, Devaney JM, Knouff CW, Thompson JR, Horne BD, Stewart AF, Assimes TL, Wild PS, Allayee H, Nitschke PL, Patel RS, Myocardial Infarction Genetics Consortium, Wellcome Trust Case Control Consortium, Martinelli N, Girelli D, Quyyumi AA, Anderson JL, Erdmann J, Hall AS, Schunkert H, Quertermous T, Blankenberg S, Hazen SL, Roberts R, Kathiresan S, Samani NJ, Epstein SE, Rader DJ
  (2011) Lancet 377: 383-92
• A potent pressor response elicited by drinking water.
  Jordan J, Shannon JR, Grogan E, Biaggioni I, Robertson D
  (1999) Lancet 353: 723
• New option for primary stroke prevention in sickle cell anaemia.
  DeBaun MR, Kirkham FJ
  (2016) Lancet 387: 626-7
• Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency.
  Biaggioni I, Robertson D
  (1987) Lancet 2: 1170-2
• Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1.
  Stringer JS, Sinkala M, Goldenberg R, Vermund S, Acosta E
  (2003) Lancet 362: 667
• Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
  Zhou MM, Ravichandran KS, Olejniczak EF, Petros AM, Meadows RP, Sattler M, Harlan JE, Wade WS, Burakoff SJ, Fesik SW
  (1995) Nature 378: 584-92
• A stomatin-like protein necessary for mechanosensation in C. elegans.
  Huang M, Gu G, Ferguson EL, Chalfie M
  (1995) Nature 378: 292-5
• Endotoxin-sensitive membrane component of human platelets.
  Hawiger J, Hawiger A, Timmons S
  (1975) Nature 256: 125-7
• Adenosine diphosphate induces binding of von Willebrand factor to human platelets.
  Fujimoto T, Hawiger J
  (1982) Nature 297: 154-6
• Regulatory factor linked to late-onset diabetes?
  Dutta S, Bonner-Weir S, Montminy M, Wright C
  (1998) Nature 392: 560
• Solution structure of a pleckstrin-homology domain.
  Yoon HS, Hajduk PJ, Petros AM, Olejniczak ET, Meadows RP, Fesik SW
  (1994) Nature 369: 672-5
• Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor.
  Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T
  (1995) Nature 377: 748-50
• High frequency of shared clonotypes in human B cell receptor repertoires.
  Soto C, Bombardi RG, Branchizio A, Kose N, Matta P, Sevy AM, Sinkovits RS, Gilchuk P, Finn JA, Crowe JE
  (2019) Nature 566: 398-402
• Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
  Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol A, Välimäki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR, Keppler-Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB, Bettinelli A, Fadrowski JJ, Belsha CW, Hunley TE, Nelson RD, Trachtman H, Cole TR, Pinsk M, Bockenhauer D, Shenoy M, Vaidyanathan P, Foreman JW, Rasoulpour M, Thameem F, Al-Shahrouri HZ, Radhakrishnan J, Gharavi AG, Goilav B, Lifton RP
  (2012) Nature 482: 98-102
• Disruption of IRS-2 causes type 2 diabetes in mice.
  Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF
  (1998) Nature 391: 900-4
• Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
  Hawiger J, Parkinson S, Timmons S
  (1980) Nature 283: 195-7
• Perspective: thinking beyond survival.
  DeBaun MR
  (2014) Nature 515: S16
• Integrin-linked kinase is an adaptor with essential functions during mouse development.
  Lange A, Wickström SA, Jakobson M, Zent R, Sainio K, Fässler R
  (2009) Nature 461: 1002-6
• Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.
  Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM
  (2001) Nature 413: 131-8
• Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate.
  Harlan JE, Hajduk PJ, Yoon HS, Fesik SW
  (1994) Nature 371: 168-70
• Matrix metalloproteinases and the regulation of tissue remodelling.
  Page-McCaw A, Ewald AJ, Werb Z
  (2007) Nat Rev Mol Cell Biol 8: 221-33